NAS10026,990+1.35%S&P7,377+0.31%GOLD$4,075−0.94%BTC$75,818+0.09%VIX25.64−9.01%latest tape · as of 04:01 UTC
The Screen · Real Estate · REIT - Industrial
LXPLXP Industrial Trust
LXP · the NYSE · USD · Market cap $3.6B · 58 employees
LXP Industrial Trust is a publicly traded real estate investment trust (REIT) focused on Class A warehouse and distribution investments in 12 target markets across the Sunbelt and lower Midwest.
FAIL · Does not pass the screen
61.18 USD
Price as of 4 Nov 2026Daily close, not a live quoteLast reviewed 4 days ago
Screened 2026-11-04 · the tape above runs as of 04:01 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
Key facts today
Price61.18 USD at the 4 Nov 2026 close
Our value readFair vs our fair value, as of 4 Nov 2026
Positioning no disclosures inside 60 days, left as found
Options put/call open interest 0.02, read 2026-11-01
Ethical does not pass the values gate
Price61.18 USD
Fair value61.00
Ethical score70.0/100
Value readFairas of 4 Nov 2026
Our investment reviews on this name
2026-09-04Read Accumulation60.99+0.3% to today ✓Markup gives way to Accumulation first Accumulation read since July
2026-08-05Read Markup58.51+4.6% to today ✓Accumulation gives way to Markup after a 10% rise in 5 weeks
2026-07-02Read Accumulation53.04+15.3% to today ✓First review on file: Accumulation
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
LXP Industrial Trust holds its Accumulation at $61.18. Consolidating, no directional conviction, held for 52 days.
As held on the ledger · 2026-11-04
Phase
Accumulation
Quantitative state
Consolidating, no directional conviction, held for 52 days
Price at the screen
$61.18
Valuation
31.21 trailing · -3,059.00 forward price to earnings
Values screen
FAIL· score 70.0
Beta
1.01
The Workings
Five Screens, Shown in Full
Does not pass. Debt ratio
Test
Figure
Limit
What it means
Status
Business activity
Permissible
Core business clean
Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending.
Pass
Debt load
35.64%
Below 33%
Interest-bearing debt is 35.6% of its assets, above the one-third ceiling the screen allows.
Fail
Interest-bearing cash
0.00%
Below 33%
Cash held in interest-bearing accounts and securities is 0.0% of assets, under the one-third limit.
Pass
Receivables
4.92%
Below 49%
Money owed to the company is 4.9% of assets, under the 49% limit.
Pass
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical Read
Why It Falls Short, in Plain English
LXP Industrial Trust's business is in a permissible area, but its interest-bearing debt is about 36% of the company, just over the ~33% line, so it does not pass on the financial screens.
Read as at 2026-11-07. It updates when the underlying figures move, and past reads are kept below.
Follow this verdict
Get an email when LXP's ethical verdict changes
Today LXP does not pass the screen. If new figures move it to a pass, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.
Free, no account needed. Every email has a link to stop.
What the Numbers Say It Is Worth
The Fair Value Range
Our analysis reads Fair vs our fair value, as of 4 Nov 2026: it trades above our $61.00 fair value estimate, 4.50% revenue growth.
Fair value range in USD, drawn from the 2026-11-04 screen. The gold marker is the market price at the same screen. The price runs 0.3% above the base estimate.
Where our models see it going: fair-value estimate $61.00, with a range of $56.00 to $61.20, dated to the 2026-11-04 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words
Sunbelt Warehouses Show Thin Returns at Current Prices
Picture a fleet of lorries queuing at new distribution sheds across Texas and the Midwest. The rents look reliable enough on paper, yet LXP Industrial Trust is posting falling revenue and a forward earnings multiple that has flipped deep into negative territory. With our fair value sitting just below the current share price, the margin of safety has disappeared and the opportunity rating is none.
The numbers reinforce the caution. Revenue is down three percent, return on equity sits at five percent, and the profit margin of twenty-seven percent has not translated into attractive growth or pricing power. Analysts still lean buy with a median target near our own fair value, but that consensus does not alter the thin cushion or the unknown competitive edge in a crowded industrial REIT sector.
High valuations on shrinking top-line figures often mask cyclical exposure rather than signal bargains. Currency or rate swings could quickly widen the gap between price and value. Ethical screen cleared, yet the investment case does not stack up. Analysis, not advice.
Another profit measure, before interest, tax and non-cash costs: EBITDA.
The risks · The main risks here are ordinary market swings and the chance our fair-value read proves too optimistic.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade
LXP trades on the NYSE. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The Dated Journal · Newest First, Never Edited
Every Entry, As Written
2026-11-03Accumulation$61.18+0.1%Entry 14
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 0.1% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 15% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 29%. Our forward projection puts the odds of a 10% gain over the next month near 17%. The street (6 analysts) rates it buy, with a mean price target of $54.
2026-10-27Accumulation$61.09+0.0%Entry 13
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 15% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 29%. Our forward projection puts the odds of a 10% gain over the next month near 17%. The street (6 analysts) rates it buy, with a mean price target of $54. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-26Accumulation$61.09+0.0%Entry 12
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 15% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 29%. Our forward projection puts the odds of a 10% gain over the next month near 17%. The street (6 analysts) rates it buy, with a mean price target of $54. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-25Accumulation$61.09+0.0%Entry 11
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 16% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 29%. Our forward projection puts the odds of a 10% gain over the next month near 17%. The street (6 analysts) rates it buy, with a mean price target of $54. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-24Accumulation$61.09+0.0%Entry 10
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 16% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 29%. Our forward projection puts the odds of a 10% gain over the next month near 17%. The street (6 analysts) rates it buy, with a mean price target of $54. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-23Accumulation$61.09+0.0%Entry 9
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 16% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 29%. Our forward projection puts the odds of a 10% gain over the next month near 17%. The street (6 analysts) rates it buy, with a mean price target of $54. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-22Accumulation$61.09+0.1%Entry 8
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 0.1% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 16% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 29%. Our forward projection puts the odds of a 10% gain over the next month near 17%. The street (6 analysts) rates it buy, with a mean price target of $54. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-16Accumulation$61.01+0.2%Entry 7
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 0.2% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it A, carrying a low risk profile. Technically it is holding around 11% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 29%. Our forward projection puts the odds of a 10% gain over the next month near 17%. The street (6 analysts) rates it buy, with a mean price target of $54.
2026-10-02Accumulation$60.86-0.2%Entry 6
Our analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.2% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 11% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 29%. Our forward projection puts the odds of a 10% gain over the next month near 17%. The street (6 analysts) rates it buy, with a mean price target of $54.
The framework has shifted from markup to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 4.2% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 11% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 29%. Our forward projection puts the odds of a 10% gain over the next month near 17%. The street (6 analysts) rates it buy, with a mean price target of $54.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.